Harvard Bioscience, Inc. (HBIO)
7.55
+0.07
(+0.94%)
USD |
NASDAQ |
Aug 24, 16:00
7.34
-0.21
(-2.78%)
After-Hours: 20:00
Harvard Bioscience Total Assets (Quarterly) : 76.29M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 76.29M |
| March 31, 2026 | 77.94M |
| December 31, 2025 | 80.07M |
| September 30, 2025 | 77.99M |
| June 30, 2025 | 80.09M |
| March 31, 2025 | 79.80M |
| December 31, 2024 | 126.64M |
| September 30, 2024 | 131.24M |
| June 30, 2024 | 128.91M |
| March 31, 2024 | 133.16M |
| December 31, 2023 | 137.37M |
| September 30, 2023 | 139.74M |
| June 30, 2023 | 142.90M |
| March 31, 2023 | 145.58M |
| December 31, 2022 | 145.36M |
| September 30, 2022 | 147.01M |
| June 30, 2022 | 155.27M |
| March 31, 2022 | 158.04M |
| December 31, 2021 | 162.34M |
| September 30, 2021 | 153.87M |
| June 30, 2021 | 153.97M |
| March 31, 2021 | 151.25M |
| December 31, 2020 | 156.25M |
| September 30, 2020 | 149.61M |
| June 30, 2020 | 150.68M |
| Date | Value |
|---|---|
| March 31, 2020 | 156.26M |
| December 31, 2019 | 164.87M |
| September 30, 2019 | 162.78M |
| June 30, 2019 | 166.24M |
| March 31, 2019 | 171.34M |
| December 31, 2018 | 168.61M |
| September 30, 2018 | 165.04M |
| June 30, 2018 | 165.05M |
| March 31, 2018 | 170.95M |
| December 31, 2017 | 109.35M |
| September 30, 2017 | 110.68M |
| June 30, 2017 | 108.86M |
| March 31, 2017 | 107.40M |
| December 31, 2016 | 107.76M |
| September 30, 2016 | 112.18M |
| June 30, 2016 | 114.08M |
| March 31, 2016 | 117.88M |
| December 31, 2015 | 120.22M |
| September 30, 2015 | 133.56M |
| June 30, 2015 | 138.58M |
| March 31, 2015 | 134.12M |
| December 31, 2014 | 135.92M |
| September 30, 2014 | 136.13M |
| June 30, 2014 | 137.71M |
| March 31, 2014 | 135.29M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Agilent Technologies, Inc. | 13.06B |
| Bio-Rad Laboratories, Inc. | 10.25B |
| Bruker Corp. | 6.053B |
| Danaher Corp. | 92.37B |
| Illumina, Inc. | 6.65B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 68.87M |
| Shareholders Equity (Quarterly) | 7.418M |
| Debt to Equity Ratio | 5.959 |
| Current Ratio | 1.874 |
| Net Debt Paydown Yield | 0.29% |